Search research articles
Contact Us
Filters
Showing results (321-330 of 389) with videos related to
Page
of 39
Sort By:
Frontiers in Neuroendocrinology
|
October 6, 2001
Hypothalamic hormones and cancer
A V Schally, A M Comaru-Schally, A Nagy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2004
Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors
Gabor L Toller, Judit E Horvath, Andrew V Schally, et al.
International Journal of Oncology
|
October 4, 2007
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone
Sandra Sotomayor, María J Carmena, Andrew V Schally, et al.
Bratislavske Lekarske Listy
|
May 18, 2021
Triggering receptor expressed on myeloid cells 1 and 2 in patients with chronic maxillary sinusitis
M Tedla, M Suchankova, K Ahrendt, et al.
Frontiers in Neuroscience
|
July 5, 2022
Interpersonal Family Dynamics Relate to Hippocampal CA Subfield Structure
Christine Coughlin, Eliya Ben-Asher, Hannah E Roome, et al.
Immunology Letters
|
November 1, 1995
In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons
T Hidvégi, B Schmidt, L Varga, et al.
Allergy
|
October 3, 2012
Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey
H Farkas, Z Zotter, D Csuka, et al.
British Journal of Cancer
|
May 19, 2000
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
K Szepeshazi, A V Schally, K Groot, et al.
Orvosi Hetilap
|
October 2, 1994
[Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study]
L Romics, I Karádi, M Csanády, et al.
The Prostate
|
March 9, 2005
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
Page
of 39
Search research articles
Search
Showing results (321-330 of 389) with videos related to
Sort By:
Page
of 39
Frontiers in Neuroendocrinology
|
October 6, 2001
Hypothalamic hormones and cancer
A V Schally, A M Comaru-Schally, A Nagy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2004
Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors
Gabor L Toller, Judit E Horvath, Andrew V Schally, et al.
International Journal of Oncology
|
October 4, 2007
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone
Sandra Sotomayor, María J Carmena, Andrew V Schally, et al.
Bratislavske Lekarske Listy
|
May 18, 2021
Triggering receptor expressed on myeloid cells 1 and 2 in patients with chronic maxillary sinusitis
M Tedla, M Suchankova, K Ahrendt, et al.
Frontiers in Neuroscience
|
July 5, 2022
Interpersonal Family Dynamics Relate to Hippocampal CA Subfield Structure
Christine Coughlin, Eliya Ben-Asher, Hannah E Roome, et al.
Immunology Letters
|
November 1, 1995
In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons
T Hidvégi, B Schmidt, L Varga, et al.
Allergy
|
October 3, 2012
Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey
H Farkas, Z Zotter, D Csuka, et al.
British Journal of Cancer
|
May 19, 2000
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
K Szepeshazi, A V Schally, K Groot, et al.
Orvosi Hetilap
|
October 2, 1994
[Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study]
L Romics, I Karádi, M Csanády, et al.
The Prostate
|
March 9, 2005
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
Page
of 39